NEW YORK, Oct. 27, 2024 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Evolv Technologies Holdings, Inc. EVLV for potential violations of the federal securities laws.

If you invested in Evolv Technologies, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/evolv-technologies-holdings-inc.

Why Did Evolv Technologies’s Stock Drop?

On October 25, 2024, Evolv announced a delay in filing its upcoming quarterly financial report due to an internal investigation revealing material misstatements in revenue recognition dating back to 2022. Evolv also announced that certain financial statements from 2022 to mid-2024 should not be relied upon, as sales to channel partners, including one of Evolv’s largest channel partners, involved undisclosed terms impacting reported revenue. 

The news has caused a precipitous decline in the price of Evolv stock.  During trading on October 25, 2024, the price of Evolv stock declined more than 40%. 

Click here for more information: https://www.bfalaw.com/cases-investigations/evolv-technologies-holdings-inc.

What Can You Do?

If you invested in Evolv Technologies you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases-investigations/evolv-technologies-holdings-inc

Or contact:
Ross Shikowitz
ross@bfalaw.com
212-789-3619

Why Bleichmar Fonti & Auld LLP?

Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases-investigations/evolv-technologies-holdings-inc

Attorney advertising. Past results do not guarantee future outcomes.